Hippocratic AI announced several executive appointments to support the continued growth and responsible scaling of its generative AI healthcare agents. The additions follow the company’s
At the World Economic Forum in Davos, Munjal Shah joined leaders from HP, BCG, Amini, and Workera to discuss the role of AI as an
Hippocratic AI is emerging as a key participant in healthcare’s transition to fully operational agentic AI in 2026, as organizations respond to severe workforce shortages
At World Economic Forum 2026, technology leaders emphasized that artificial intelligence is reshaping work by automating tasks rather than replacing entire human jobs. Executives noted
Health systems such as WellSpan and Geisinger are using artificial intelligence to expand patient access, reduce clinical workload, and support safer care while keeping humans
Hippocratic AI is focused on addressing clinician shortages by deploying safety-first, patient-facing AI agents that augment healthcare teams with scalable, always-available support. Its voice-enabled patient
The rapid growth of AI agents has made them one of the fastest-scaling software categories by 2026, with the global market expanding from $5.25 billion
At the J.P. Morgan Healthcare Conference, Hippocratic AI announced a strategic expansion into the life sciences sector through the acquisition of Grove AI, a company
In a year marked by sustained momentum in large-scale AI funding, Hippocratic AI stood out among U.S.-based startups raising $100 million or more in 2025.
On January 8, 2026, Hippocratic AI announced a collaboration with Huron Consulting Group to deploy generative AI healthcare agents across Huron-led transformation initiatives serving more
On January 8, 2026, Hippocratic AI announced a collaboration with Huron Consulting Group to deploy safety-focused generative AI healthcare agents across Huron-led healthcare transformation programs.
Hippocratic AI announced a collaboration with Huron Consulting Group focused on applying generative AI to healthcare operations and patient support, including care navigation after discharge,
At the J.P. Morgan Healthcare Conference, Hippocratic AI announced an expansion into the life sciences sector through the acquisition of Grove AI. Grove AI’s technology
Hippocratic AI expanded into life sciences through the acquisition of Grove AI, adding clinical trial–focused agentic AI to its existing patient-facing healthcare platform. The move
At a Boston Consulting Group event held alongside the JPM Healthcare Conference, Hippocratic AI was highlighted as an example of how AI can address structural
Hippocratic AI expanded its life sciences business through the acquisition of Grove AI, the launch of a dedicated Life Sciences Division, and the formation of
Hippocratic AI expanded into the life sciences sector through the acquisition of Grove AI, adding agentic AI capabilities for pharmaceutical research, development, and clinical trial
Hippocratic AI reported rapid expansion across providers, payors, life sciences, and the public sector following its $126 million Series C round at a $3.5 billion
Hippocratic AI announced a global collaboration with Boston Consulting Group to deploy generative AI healthcare agents across biopharma and medtech organizations. The partnership combines Hippocratic
Hippocratic AI expanded its life sciences footprint with the acquisition of Grove AI, adding agentic AI capabilities for pharmaceutical R&D and clinical trial operations to